Evidence map›Paper›PMID 36223556›Full record

ArticleJCO oncology practice2023

IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases.

Nicole M Grogan Fleege, Donna Pierce-Gjeldum, Leigh K Swartz, Kait Verbal, Sofia Merajver, Christopher R Friese, Ayano Kiyota, Jason Heth, Denise Leung, Sean R Smith and 3 more

Abstract read
In one paragraph

Article in JCO oncology practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nicole M Grogan FleegeUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0001-6214-2790
Donna Pierce-GjeldumUniversity of Michigan Health System, Ann Arbor, MI.
Leigh K SwartzHunter Holmes McGuire VAMC, Richmond, VA.
Kait VerbalUniversity of Michigan Health System, Ann Arbor, MI.
Sofia MerajverUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0002-6823-7130
Christopher R FrieseUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0002-2281-2056
Ayano KiyotaUniversity of Michigan Health System, Ann Arbor, MI.
Jason HethUniversity of Michigan Health System, Ann Arbor, MI.
Denise LeungUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0003-4302-0098
Sean R SmithUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0001-9936-8750
Nicolette GabelUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0002-0239-6403
Michelle M KimUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0001-7566-6411
Aki MorikawaUniversity of Michigan Health System, Ann Arbor, MI.ORCID 0000-0002-4764-4896

Funding

Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligenceR33CA261696 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FU, JIANPING, MERAJVER, SOFIA DIANA · 2022 to 2024
$1.1M
NCI NIH HHS R33 CA261696
6 · The paper itself

Abstract

purposeCNS metastases are associated with decreased survival and quality of life for patients with metastatic breast cancer (MBC). Team-based care can optimize outcomes. IMPACT the Brain is a care coordination program that aims to improve access to team-based care for patients with MBC and CNS metastases. MATERIALS AND

methodsPatients with MBC and CNS metastases were eligible for enrollment in this care coordination program. A team of specialists supported a dedicated program coordinator who provided navigation, education, specialty referral, and clinical trial screening. A unique intake form developed for the program created personalized, coordinated, and expedited specialty referrals. Patient-reported outcomes and caregiver burden assessments were collected on a voluntary basis throughout enrollment. Data were analyzed using descriptive statistics.

resultsSixty patients were referred, and 53 were enrolled (88%). The median time to program enrollment was 1 day (range, 0-11) and to first visit was 5 days (range, 0-25). On the basis of the program intake form, 47 referrals were made across six specialties, most commonly physical medicine and rehabilitation (n = 10), radiation oncology (n = 10), and neuropsychology (n = 10). Nineteen patients (36%) consented to enroll in clinical trials.

conclusionA tailored team-based care coordination program for patients with MBC and CNS metastases is feasible. Use of a unique intake screening form by a dedicated program coordinator resulted in faster time to first patient visit, enabled access to subspecialist care, and supported enrollment in clinical trials. Future research should focus on intervention development using PRO data collected in this care coordination program.

Indexed as

Breast NeoplasmsCentral Nervous System NeoplasmsBrainFemaleHumansQuality of Life

Identifiers

PMID36223556
PMCPMC9870235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.